ABEL ORTEGA DIAZ: Open Payments
NPI 1689111957 · CASA GRANDE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$537 in 29 payments from 9 companies in 2025. Trend: 2023 $129 · 2024 $170 · 2025 $537
Food & beverage: $537
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 9 | $166 |
| AstraZeneca Pharmaceuticals LP | 8 | $152 |
| ABBVIE INC. | 3 | $65 |
| Novo Nordisk Inc | 2 | $35 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $33 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $32 |
| Merck Sharp & Dohme LLC | 1 | $22 |
| Exact Sciences Corporation | 1 | $18 |
| Lilly USA, LLC | 1 | $14 |
Products named: EVENITY, OTEZLA, BYETTA, VRAYLAR, AIRSUPRA, XIFAXAN, Kerendia, ROTATEQ.
Industry payments across AZ — which companies pay providers there.
